We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00907309
First Posted: May 22, 2009
Last Update Posted: October 7, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Cambridge Health Alliance
Tufts Medical Center
Harvard School of Dental Medicine
Fallon Clinic
Information provided by (Responsible Party):
John R Knight, MD, Boston Children's Hospital
  Purpose
The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.

Condition Intervention Phase
Use; Tobacco, Harmful Alcohol Abuse Drug Abuse Behavioral: iMET Behavioral: iMET/TE Phase 1 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Dental and Medical Office Internet/Intranet Motivational Enhancement Therapy to Reduce Teen Tobacco, Alcohol, and Drug Use

Further study details as provided by John R Knight, MD, Boston Children's Hospital:

Primary Outcome Measures:
  • Frequency of tobacco, alcohol, marijuana, and other drug use [ Time Frame: 3 months, 6 months ]

Secondary Outcome Measures:
  • Rates of initiation and cessation of tobacco, alcohol, marijuana and other drug use [ Time Frame: 3 months, 6 months ]

Enrollment: 121
Study Start Date: September 2010
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Treatment as usual
Participants will receive treatment as usual from their provider.
Experimental: iMET
Participants will receive the iMET intervention.
Behavioral: iMET
Participants will receive the iMET intervention
Experimental: iMET/TE
Participants will receive the iMET intervention and Technological Extenders (TEs).
Behavioral: iMET/TE
Participants will receive the iMET intervention and also receive TEs (Technological Extenders)

Detailed Description:
We have previously developed and tested in a treatment population a promising MET program for alcohol and drug use. We will broaden the MET intervention to also target tobacco use and convert the new materials into a self-administered format.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 12-21 years old
  • Coming for routine care

Exclusion Criteria:

  • Medically or emotionally unstable day of visit
  • Already receiving behavioral health services
  • Cannot read/understand English
  • Will not be available for post-tests
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00907309


Locations
United States, Massachusetts
Children's Hospital Boston
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Boston Children’s Hospital
Cambridge Health Alliance
Tufts Medical Center
Harvard School of Dental Medicine
Fallon Clinic
Investigators
Principal Investigator: John R. Knight, MD Boston Children’s Hospital
  More Information

Additional Information:
Responsible Party: John R Knight, MD, Associate Professor of Pediatrics, Harvard Medical School; Senior Associate in Medicine; Associate in Psychiatry, Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital, Boston Children's Hospital
ClinicalTrials.gov Identifier: NCT00907309     History of Changes
Other Study ID Numbers: iMET RFA-OD-09-003
First Submitted: May 20, 2009
First Posted: May 22, 2009
Last Update Posted: October 7, 2016
Last Verified: October 2016

Keywords provided by John R Knight, MD, Boston Children's Hospital:
alcohol abuse
marijuana abuse
drug abuse
tobacco use
tobacco dependence

Additional relevant MeSH terms:
Alcoholism
Substance-Related Disorders
Alcohol-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs